- Home
- JANX vs ASH Comparison
JANX vs ASH Comparison
Compare JANX & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- ASH
- Stock Information
- Founded
- JANX 2017
- ASH 1924
- Country
- JANX United States
- ASH United States
- Employees
- JANX N/A
- ASH N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- ASH Specialty Chemicals
- Sector
- JANX Health Care
- ASH Consumer Discretionary
- Exchange
- JANX Nasdaq
- ASH Nasdaq
- Market Cap
- JANX 3.6B
- ASH 4.1B
- IPO Year
- JANX 2021
- ASH N/A
- Fundamental
- Price
- JANX $56.83
- ASH $71.98
- Analyst Decision
- JANX Strong Buy
- ASH Buy
- Analyst Count
- JANX 11
- ASH 7
- Target Price
- JANX $83.09
- ASH $101.00
- AVG Volume (30 Days)
- JANX 1.7M
- ASH 497.8K
- Earning Date
- JANX 11-06-2024
- ASH 01-28-2025
- Dividend Yield
- JANX N/A
- ASH 2.25%
- EPS Growth
- JANX N/A
- ASH 1.05
- EPS
- JANX N/A
- ASH 3.35
- Revenue
- JANX $13,049,000.00
- ASH $2,113,000,000.00
- Revenue This Year
- JANX $40.27
- ASH N/A
- Revenue Next Year
- JANX N/A
- ASH $4.14
- P/E Ratio
- JANX N/A
- ASH $18.19
- Revenue Growth
- JANX 54.12
- ASH N/A
- 52 Week Low
- JANX $7.79
- ASH $71.56
- 52 Week High
- JANX $71.71
- ASH $102.50
- Technical
- Relative Strength Index (RSI)
- JANX 50.66
- ASH 31.92
- Support Level
- JANX $54.20
- ASH $72.83
- Resistance Level
- JANX $66.34
- ASH $74.57
- Average True Range (ATR)
- JANX 5.47
- ASH 1.64
- MACD
- JANX -0.57
- ASH -0.21
- Stochastic Oscillator
- JANX 15.02
- ASH 9.96
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.